Portfolio Companies

New View Surgical - novel VisionPort™ System is the first surgeon-controlled, multi-camera laparoscopic visualization system.

Developing a pipeline of best-in-class oncolytic immunotherapeutics that are highly effective in treating cancer patients with solid cancers.

Novel neuroprotective therapeutics for the treatment of stroke, traumatic brain injury (TBI), concussion, and neurodegenerative diseases

A mesh-free approach for pelvic floor fixation for Pelvic Organ Prolapse (POP), which is a painful, debilitating medical condition that occurs when the normal support of the vagina is lost, resulting in the “sagging” or dropping of the female pelvic organs.

Cerus Endovascular is engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems, which it believes will represent the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms.

Healionics is a clinical stage company addressing the critical need for improved means of dialysis access in patients with kidney failure. Healionics’ STARgraft vascular graft (artificial blood vessel) resists the problems of occlusion and infection suffered by current devices. The company is also developing a product pipeline based on its platform STAR® biomaterial, which has a unique ability to prevent both scarring and infection in a wide variety of other implantable device applications.